stock-detail (Kura)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

4/24/2017 12:18 pm

4/24/2017 12:18 pm

4/24/2017 12:18 pm

4/24/2017 12:18 pm

4/19/2017 06:18 am

4/19/2017 06:18 am

4/19/2017 06:18 am

4/7/2017 06:17 am

4/7/2017 06:17 am

4/7/2017 06:17 am

Preclinical Data for Kura Oncology Development Compounds to be Presented at AACR Annual Meeting 2017

3/29/2017 11:03 am

[GlobeNewswire] - LA JOLLA, Calif., March 29, 2017-- Kura Oncology, Inc., a clinical stage biopharmaceutical company focused on the development of precision medicines, today announced that results from preclinical studies ...

Kura Oncology Reports Fourth Quarter and Full Year 2016 Operational and Financial Results

3/14/2017 08:00 pm

[GlobeNewswire] - LA JOLLA, Calif., March 14, 2017-- Kura Oncology, Inc., a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology, today reported fourth quarter and full ...

Kura Oncology to Report Fourth Quarter and Full Year 2016 Financial Results

3/7/2017 09:00 pm

[GlobeNewswire] - LA JOLLA, Calif., March 07, 2017-- Kura Oncology, Inc., a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it will report fourth ...

Kura Oncology Reports Updated Clinical Activity Data in Ongoing Phase 2 Trial for Tipifarnib

3/6/2017 12:03 pm

[GlobeNewswire] - LA JOLLA, Calif., March 06, 2017-- Kura Oncology, Inc., a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced updated results from the ...

Kura Oncology Announces Presentation of Preliminary Clinical Data for Tipifarnib in HRAS Mutant Squamous Cell Carcinomas of the Head and Neck at TAT 2017

2/27/2017 12:03 pm

[GlobeNewswire] - LA JOLLA, Calif., Feb. 27, 2017-- Kura Oncology, Inc., a clinical stage biopharmaceutical company, today announced an oral presentation for its lead product candidate, tipifarnib, at the 15 th International ...

Kura Oncology to Participate in Three Upcoming Investor Conferences

2/9/2017 09:00 pm

[GlobeNewswire] - LA JOLLA, Calif., Feb. 09, 2017-- Kura Oncology, Inc., a clinical stage biopharmaceutical company, today announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to ...